Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis

Promrat, Kittichai; E. Kleiner, David; M. Niemeier, Heather; H. Jackvony, Elizabeth; Kearns, Marie; R. Wands, Jack; L. Fava, Joseph; R. Wing, Rena

doi:10.1002/hep.23276

Public

Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis

Published in Hepatology • Sep 9, 2009

Authors:

Kittichai Promrat

David E. Kleiner

Heather M. Niemeier

Abstract

UNLABELLED: Nonalcoholic steatohepatitis (NASH) is a chronic progressive liver disease that is strongly associated with obesity. Currently, there is no approved therapy for NASH. Weight reduction is typically recommended, but efficacy data are lacking. We performed a randomized controlled trial to e...

Subject

Nonalcoholic steatohepatitis

Randomized controlled trial

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!